Delivery Order SPE2DB22D3301-SPE2DB23FZ2VZ
Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,389 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562290966 units of the drug remifentanil hydrochloride in 1 mg vials. As the prime contractor, Amerisourcebergen will deliver the ordered pharmaceutical products to a location in Conshohocken, Pennsylvania by September 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $3,546 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 1 mg vials of the drug remifentanil to the Defense Logistics Agency for use at its location in Conshohocken, Pennsylvania. The single-day period of performance spans August 10-11, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will serve as the prime contractor on the delivery...
- The Defense Logistics Agency awarded a $2,354 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562048946 units of 1 mg vials of remifentanil. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 6, 2023 in support of DLA programs. Remifentanil is an opioid analgesic for medical use as an anesthetic adjunct. This order was awarded under an existing DLA pharmaceutical supply vehicle and no set aside designation...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,370.48 for Remifentanil 2 mg vials, with an ultimate completion date of September 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,980.40 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, issued on November 13, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and pharmaceutical distribution operations. This...
- The Defense Logistics Agency awarded a $1,919.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This competitively awarded contract, which has no set-aside designation, was executed on July 9, 2025, with an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,635.77 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,338.73 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,983.47 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, a potent opioid analgesic commonly used in clinical and surgical settings. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,466.92 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, awarded on October 17, 2025, with an ultimate completion date of October 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent opioid analgesic commonly used in...